Stock Earnings

Question 1

Soleno Therapeutics Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Soleno Therapeutics Inc 的总资产为 $330，净loss为 $-175

Question 2

SLNO 的关键财务比率是什么？

Accepted Answer

Soleno Therapeutics Inc 的流动比率是 3.88，净利 margin 为 0，每股销售为 $0。

Question 3

Soleno Therapeutics Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Currently Soleno Therapeutics Inc data is not available.

Question 4

Soleno Therapeutics Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Soleno Therapeutics Inc 的净loss为 $-175

Question 5

Soleno Therapeutics Inc 有负债吗？

Accepted Answer

yes，Soleno Therapeutics Inc 的负债为 85

Question 6

Soleno Therapeutics Inc 的流通股有多少？

Accepted Answer

Soleno Therapeutics Inc 的总流通股为 45.7

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	32	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	--	--	--	--	--
Gross Profit	31	--	--	--	--	--
Selling, General & Admin	143	105	13	9	10	8
Research & Development	74	78	25	15	21	23
Operating Expenses	223	187	41	24	31	36
Other Non Operating Income (Expenses)	--	0	0	0	0	11
Pretax Income	-181	-175	-38	-24	-30	-24
Income Tax Expense	--	--	--	--	--	--
Net Income	-181	-175	-38	-24	-30	-24
Net Income Growth	178%	361%	57.99%	-20%	25%	-20%
Shares Outstanding (Diluted)	50.48	40.17	16.49	8.4	5.32	4.17
Shares Change (YoY)	28.99%	144%	96%	57.99%	28%	83%
EPS (Diluted)	-3.58	-4.37	-2.36	-2.87	-5.81	-5.9
EPS Growth	113.99%	85%	-18%	-51%	-2%	-56%
Free Cash Flow	-84	-69	-24	-20	-27	-25
Free Cash Flow Per Share	-1.66	-1.71	-1.45	-2.38	-5.07	-5.99
Gross Margin	96.87%	--	--	--	--	--
Operating Margin	-596.87%	0%	0%	0%	0%	0%
Profit Margin	-565.62%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-262.5%	0%	0%	0%	0%	0%
EBITDA	-189	-186	-40	-23	-30	-35
EBITDA Margin	-590.62%	0%	0%	0%	0%	0%
D&A For EBITDA	2	1	1	1	1	1
EBIT	-191	-187	-41	-24	-31	-36
EBIT Margin	-596.87%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Soleno Therapeutics Inc (SLNO) Price